Carvacrol-conjugated 3-Hydroxybenzoic Acids: Design, Synthesis, cardioprotective potential against doxorubicin-induced Cardiotoxicity, and ADMET study.

Autor: Retnosari R; Department of Chemical Sciences, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, 43600 UKM Bangi, Selangor, Malaysia; International Joint Department of Materials Science and Engineering Between National University of Malaysia and Gifu University, Graduate School of Engineering, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan; Department of Chemistry, Universitas Negeri Malang, Jl. Semarang No. 5 Malang, Indonesia., Oh-Hashi K; Department of Chemistry and Biomolecular Science, Faculty of Engineering, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan; United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, 1-1 Yanagido, Gifu 501- 1193, Japan; Center for One Medicine Innovative Translational Research (COMIT), Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan., Ugusman A; Department of Physiology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia; Cardiovascular and Pulmonary (CardioResp) Research Group, Universiti Kebangsaan Malaysia, 43600 Bangi, Selangor, Malaysia., Zainalabidin S; Programme of Biomedical Science, Centre for Toxicology and Health Risk Studies (CORE), Faculty of Health Sciences, Universiti Kebangsaan Malaysia, 50300 Kuala Lumpur, Malaysia; Cardiovascular and Pulmonary (CardioResp) Research Group, Universiti Kebangsaan Malaysia, 43600 Bangi, Selangor, Malaysia., Latip J; Department of Chemical Sciences, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, 43600 UKM Bangi, Selangor, Malaysia; Smart Material and Sustainable Product Innovation (SMatSPIn) Research, Universiti Kebangsaan Malaysia, UKM Bangi 43600, Selangor, Malaysia. Electronic address: jalifah@ukm.edu.my., Oka N; International Joint Department of Materials Science and Engineering Between National University of Malaysia and Gifu University, Graduate School of Engineering, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan; Department of Chemistry and Biomolecular Science, Faculty of Engineering, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan; Center for One Medicine Innovative Translational Research (COMIT), Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan; Institute for Glyco-core Research (iGCORE), Gifu University, Gifu 501-1193, Japan. Electronic address: oka.natsuhisa.f9@f.gifu-u.ac.jp.

Publikováno v: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2024 Nov 15; Vol. 113, pp. 129973. Date of Electronic Publication: 2024 Sep 22.

The Efficacy and Safety of Levosimendan in Patients with Advanced Heart Failure: An Updated Meta-Analysis of Randomized Controlled Trials.

Autor: Elsaeidy AS; Faculty of Medicine, Benha University, Benha, Egypt. AhmedSaadElsaeidy@gmail.com., Abuelazm M; Faculty of Medicine, Tanta University, Tanta, Egypt., Ghaly R; Department of Internal Medicine, University of Missouri-Kansas City, Kansas City, USA., Soliman Y; Faculty of Medicine, Assiut University, Assiut, Egypt., Amin AM; Faculty of Medicine, Mansoura University, Mansoura, Egypt., El-Gohary M; Department of Internal Medicine, University of Missouri-Kansas City, Kansas City, USA., Elshenawy S; Faculty of Medicine, Alexandria University, Alexandria, Egypt., Seri AR; Department of Internal Medicine, McLaren Health Care/Michigan State University, Flint, MI, USA., Abdelazeem B; Department of Cardiology, West Virginia University, West Virginia, USA., Patel B; Department of Cardiology, West Virginia University, West Virginia, USA., Bianco C; Department of Cardiology, West Virginia University, West Virginia, USA.

Publikováno v: American journal of cardiovascular drugs : drugs, devices, and other interventions [Am J Cardiovasc Drugs] 2024 Nov; Vol. 24 (6), pp. 775-790. Date of Electronic Publication: 2024 Sep 11.

Efficacy and safety of low-dose digoxin in patients with heart failure. Rationale and design of the DECISION trial.

Autor: van Veldhuisen DJ; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Rienstra M; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Mosterd A; Department of Cardiology, Meander Medisch Centrum, Amersfoort, The Netherlands.; Workgroup Cardiology Centers, Utrecht, The Netherlands., Alings AM; Workgroup Cardiology Centers, Utrecht, The Netherlands.; Department of Cardiology, Amphia Medical Center, Breda, The Netherlands., van Asselt ADJ; Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Bouvy ML; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Tijssen JGP; Department of Cardiology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Schaap J; Workgroup Cardiology Centers, Utrecht, The Netherlands.; Department of Cardiology, Amphia Medical Center, Breda, The Netherlands., van der Wall EE; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands., Voors AA; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Boorsma EM; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Lok DJA; Department of Cardiology, Deventer Hospital, Deventer, The Netherlands., Crijns HJGM; Department of Cardiology and Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands., Schut A; Workgroup Cardiology Centers, Utrecht, The Netherlands., Vijver MAT; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Voordes GHD; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., de Vos AH; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Maas-Soer EL; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Smit NW; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Touw DJ; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Samuel M; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., van der Meer P; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Publikováno v: European journal of heart failure [Eur J Heart Fail] 2024 Oct; Vol. 26 (10), pp. 2223-2230. Date of Electronic Publication: 2024 Aug 30.

Cardioprotective potential of oleuropein, hydroxytyrosol, oleocanthal and their combination: Unravelling complementary effects on acute myocardial infarction and metabolic syndrome.

Autor: Christodoulou A; Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Panepistimioupolis, Zografou, Athens, Greece., Nikolaou PE; Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Panepistimioupolis, Zografou, Athens, Greece., Symeonidi L; Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Panepistimioupolis, Zografou, Athens, Greece., Katogiannis K; Laboratory of Echocardiography and Preventive Cardiology, Second Cardiology Department, Attikon University Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece., Pechlivani L; Atherothrombosis Research Centre/Laboratory of Biochemistry, Department of Chemistry, University of Ioannina, Ioannina, Greece., Nikou T; Division of Pharmacognosy and Natural Products Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece., Varela A; Cardiovascular Research Laboratory, Biomedical Research Foundation Academy of Athens (BRFAA), Athens, Greece., Chania C; Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Panepistimioupolis, Zografou, Athens, Greece., Zerikiotis S; Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Panepistimioupolis, Zografou, Athens, Greece., Efentakis P; Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Panepistimioupolis, Zografou, Athens, Greece., Vlachodimitropoulos D; Laboratory of Forensic Medicine and Toxicology, Medical School National and Kapodistrian University of Athens, Athens, Greece., Katsoulas N; Laboratory of Forensic Medicine and Toxicology, Medical School National and Kapodistrian University of Athens, Athens, Greece., Agapaki A; Histochemistry Unit, Biomedical Research Foundation, Academy of Athens (BRFAA), Athens, Greece., Dimitriou C; Centre of Clinical Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece., Tsoumani M; Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Panepistimioupolis, Zografou, Athens, Greece., Kostomitsopoulos N; Centre of Clinical Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece., Davos CH; Cardiovascular Research Laboratory, Biomedical Research Foundation Academy of Athens (BRFAA), Athens, Greece., Skaltsounis AL; Division of Pharmacognosy and Natural Products Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece., Tselepis A; Atherothrombosis Research Centre/Laboratory of Biochemistry, Department of Chemistry, University of Ioannina, Ioannina, Greece., Halabalaki M; Division of Pharmacognosy and Natural Products Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece., Tseti I; Uni-Pharma S.A., Athens, Greece., Iliodromitis EK; National and Kapodistrian University of Athens, Medical School, Athens, Greece., Ikonomidis I; Laboratory of Echocardiography and Preventive Cardiology, Second Cardiology Department, Attikon University Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece., Andreadou I; Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Panepistimioupolis, Zografou, Athens, Greece. Electronic address: jandread@pharm.uoa.gr.

Publikováno v: Redox biology [Redox Biol] 2024 Oct; Vol. 76, pp. 103311. Date of Electronic Publication: 2024 Aug 14.

Cardioprotective Action of the JNK Inhibitor Tryptanthrin Oxime in the Late Period after Myocardial Infarction.

Autor: Plotnikov MB; Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia. mbp2001@mail.ru., Chernysheva GA; Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia., Smol'yakova VI; Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia., Aliev OI; Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia., Fomina TI; Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia., Sandrikina LA; Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia., Sukhodolo IV; Siberia State Medical University, Ministry of Health of the Russian Federation, Tomsk, Russia., Ivanova VV; Siberia State Medical University, Ministry of Health of the Russian Federation, Tomsk, Russia., Plotnikova TM; Siberia State Medical University, Ministry of Health of the Russian Federation, Tomsk, Russia., Osipenko AN; Siberia State Medical University, Ministry of Health of the Russian Federation, Tomsk, Russia., Kovrizhina AR; National Research Tomsk Polytechnic University, Tomsk, Russia., Khlebnikov AI; National Research Tomsk Polytechnic University, Tomsk, Russia.

Publikováno v: Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2024 Sep; Vol. 177 (5), pp. 643-647. Date of Electronic Publication: 2024 Sep 30.